Relay Therapeutics, Inc. RLAY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$73.29M+4.9% | -$54.89M+27.8% | -$74.15M+15.8% | -$70.38M+23.7% | -$77.07M+5.3% | ||
| $504K-58.3% | $599K-55.1% | $748K-45.3% | $1M-26.8% | $1.21M-13.4% | ||
| $10.54M-45.5% | $13.07M-25.9% | $15.53M-30.9% | $14.5M-46.0% | $19.33M-28.9% | ||
| $3.67M+206% | -$6.53M-158% | -$507K+88.2% | -$953K-130% | -$3.45M-3,478% | ||
| $384K+225% | -$615K-197% | —— | -$1.07M-20.0% | -$308K-167% | ||
| —— | —— | —— | —— | -$7.68M-500% | ||
| -$7.36M-287% | -$3.82M— | $3.97M-59.0% | -$5.69M-22.6% | $3.93M+728% | ||
| -$51.11M+30.2% | -$44.87M+22.5% | -$62.12M+17.3% | -$55.26M+16.1% | -$73.21M-45.5% | ||
| —— | $1K— | $0-100% | $26K+136% | $384K-78.4% | ||
| $50.9M+132% | $34M-54.7% | $58.08M-78.1% | $8.93M-92.5% | $21.97M-88.5% | ||
| $83.8M+29.3% | $69.46M-33.3% | $97.8M-29.7% | $84.1M-49.1% | $64.82M-68.1% | ||
| $32.9M-22.5% | $35.46M— | $39.73M+131% | $75.15M+65.0% | $42.47M+303% | ||
| $138.78M— | $934K+16.8% | $17K-100.0% | —— | —— | ||
| $120.57M+492% | -$8.47M+69.8% | -$22.38M-227% | —— | -$30.75M-437% | ||
| $782K-51.0% | $857K-60.7% | $1.1M-65.4% | $1.39M-57.6% | $1.6M-56.4% | ||
| $504K-58.3% | $599K-55.1% | $748K-45.3% | $1M-26.8% | $1.21M-13.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$7.68M-500% | ||
| -$506K-78.8% | —— | —— | $5.57M+1,798% | -$283K+19.1% | ||
| -$7.36M-287% | -$3.82M— | $3.97M-59.0% | -$5.69M-22.6% | $3.93M+728% | ||
| $1.69M— | —— | $17K-97.7% | —— | —— | ||
| $137.09M— | —— | —— | —— | —— | ||
| —— | $1.73M— | $1.73M— | $1.73M— | $1.73M— | ||
| —— | —— | —— | -$96K+42.9% | $61K+104% | ||
| $0+100% | —— | —— | —— | -$2.51M-500% | ||
| —— | -$44.87M+22.5% | -$62.12M+17.5% | -$55.29M+16.0% | -$73.59M-41.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Relay Therapeutics, Inc. generate?
- Relay Therapeutics, Inc. (RLAY) generated -$213.4M in operating cash flow over the trailing twelve months.
- Where does Relay Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
